Europe Plasma Protein Therapeutics Market Report 2017

February 2017 | 120 pages | ID: E2CEEC60F3DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Plasma Protein Therapeutics

Revenue, means the sales value of Plasma Protein Therapeutics

This report studies sales (consumption) of Plasma Protein Therapeutics in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Baxter International
• Biotest
• CSL Behring
• Grifols, S.A.
• Kedrion
• Octapharma USA
• Shire Plc
• China Biologics
• Kamada

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Plasma Protein Therapeutics in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• C1 esterase Inhibitors
• Albumins
• Immunoglobulins
• Coagulation Factors
• Others

Split by application, this report focuses on sales, market share and growth rate of Plasma Protein Therapeutics in each application, can be divided into

• Hereditary Angioedema
• Hemophilia
• Primary Immunodeficiency Disorder
• Secondary Immunodeficiency
• Idiopathic Thrombocytopenic
• Others (Kawasaki disease, GBS, CIDP etc)

Contents

Europe Plasma Protein Therapeutics Market Report 2017

1 PLASMA PROTEIN THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Plasma Protein Therapeutics
1.2 Classification of Plasma Protein Therapeutics
  1.2.1 C1 esterase Inhibitors
  1.2.2 Albumins
  1.2.3 Immunoglobulins
  1.2.4 Coagulation Factors
  1.2.5 Others
1.3 Application of Plasma Protein Therapeutics
  1.3.1 Hereditary Angioedema
  1.3.2 Hemophilia
  1.3.3 Primary Immunodeficiency Disorder
  1.3.4 Secondary Immunodeficiency
  1.3.5 Idiopathic Thrombocytopenic
  1.3.6 Others (Kawasaki disease, GBS, CIDP etc)
1.4 Plasma Protein Therapeutics Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Plasma Protein Therapeutics (2011-2021)
  1.5.1 Europe Plasma Protein Therapeutics Sales and Growth Rate (2011-2021)
  1.5.2 Europe Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)

2 EUROPE PLASMA PROTEIN THERAPEUTICS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Plasma Protein Therapeutics Market Competition by Manufacturers
  2.1.1 Europe Plasma Protein Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Plasma Protein Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Plasma Protein Therapeutics (Volume and Value) by Type
  2.2.1 Europe Plasma Protein Therapeutics Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
2.3 Europe Plasma Protein Therapeutics (Volume and Value) by Countries
  2.3.1 Europe Plasma Protein Therapeutics Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Plasma Protein Therapeutics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Plasma Protein Therapeutics (Volume) by Application

3 GERMANY PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Plasma Protein Therapeutics Sales and Value (2011-2016)
  3.1.1 Germany Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  3.1.2 Germany Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Plasma Protein Therapeutics Sales Price Trend (2011-2016)
3.2 Germany Plasma Protein Therapeutics Sales and Market Share by Manufacturers
3.3 Germany Plasma Protein Therapeutics Sales and Market Share by Type
3.4 Germany Plasma Protein Therapeutics Sales and Market Share by Application

4 FRANCE PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 France Plasma Protein Therapeutics Sales and Value (2011-2016)
  4.1.1 France Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  4.1.2 France Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  4.1.4 France Plasma Protein Therapeutics Sales Price Trend (2011-2016)
4.2 France Plasma Protein Therapeutics Sales and Market Share by Manufacturers
4.3 France Plasma Protein Therapeutics Sales and Market Share by Type
4.4 France Plasma Protein Therapeutics Sales and Market Share by Application

5 UK PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Plasma Protein Therapeutics Sales and Value (2011-2016)
  5.1.1 UK Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  5.1.2 UK Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  5.1.5 UK Plasma Protein Therapeutics Sales Price Trend (2011-2016)
5.2 UK Plasma Protein Therapeutics Sales and Market Share by Manufacturers
5.3 UK Plasma Protein Therapeutics Sales and Market Share by Type
5.4 UK Plasma Protein Therapeutics Sales and Market Share by Application

6 RUSSIA PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Plasma Protein Therapeutics Sales and Value (2011-2016)
  6.1.1 Russia Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  6.1.2 Russia Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Plasma Protein Therapeutics Sales Price Trend (2011-2016)
6.2 Russia Plasma Protein Therapeutics Sales and Market Share by Manufacturers
6.3 Russia Plasma Protein Therapeutics Sales and Market Share by Type
6.4 Russia Plasma Protein Therapeutics Sales and Market Share by Application

7 ITALY PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Plasma Protein Therapeutics Sales and Value (2011-2016)
  7.1.1 Italy Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  7.1.2 Italy Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Plasma Protein Therapeutics Sales Price Trend (2011-2016)
7.2 Italy Plasma Protein Therapeutics Sales and Market Share by Manufacturers
7.3 Italy Plasma Protein Therapeutics Sales and Market Share by Type
7.4 Italy Plasma Protein Therapeutics Sales and Market Share by Application

8 SPAIN PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Plasma Protein Therapeutics Sales and Value (2011-2016)
  8.1.1 Spain Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  8.1.2 Spain Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Plasma Protein Therapeutics Sales Price Trend (2011-2016)
8.2 Spain Plasma Protein Therapeutics Sales and Market Share by Manufacturers
8.3 Spain Plasma Protein Therapeutics Sales and Market Share by Type
8.4 Spain Plasma Protein Therapeutics Sales and Market Share by Application

9 BENELUX PLASMA PROTEIN THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Plasma Protein Therapeutics Sales and Value (2011-2016)
  9.1.1 Benelux Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Plasma Protein Therapeutics Sales Price Trend (2011-2016)
9.2 Benelux Plasma Protein Therapeutics Sales and Market Share by Manufacturers
9.3 Benelux Plasma Protein Therapeutics Sales and Market Share by Type
9.4 Benelux Plasma Protein Therapeutics Sales and Market Share by Application

10 EUROPE PLASMA PROTEIN THERAPEUTICS MANUFACTURERS ANALYSIS

10.1 Baxter International
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.1.2.1 C1 esterase Inhibitors
    10.1.2.2 Albumins
  10.1.3 Baxter International Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Biotest
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.2.2.1 C1 esterase Inhibitors
    10.2.2.2 Albumins
  10.2.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 CSL Behring
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.3.2.1 C1 esterase Inhibitors
    10.3.2.2 Albumins
  10.3.3 CSL Behring Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Grifols, S.A.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.4.2.1 C1 esterase Inhibitors
    10.4.2.2 Albumins
  10.4.3 Grifols, S.A. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Kedrion
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.5.2.1 C1 esterase Inhibitors
    10.5.2.2 Albumins
  10.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Octapharma USA
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.6.2.1 C1 esterase Inhibitors
    10.6.2.2 Albumins
  10.6.3 Octapharma USA Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Shire Plc
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.7.2.1 C1 esterase Inhibitors
    10.7.2.2 Albumins
  10.7.3 Shire Plc Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 China Biologics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.8.2.1 C1 esterase Inhibitors
    10.8.2.2 Albumins
  10.8.3 China Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Kamada
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Plasma Protein Therapeutics Product Type, Application and Specification
    10.9.2.1 C1 esterase Inhibitors
    10.9.2.2 Albumins
  10.9.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview

11 PLASMA PROTEIN THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 Plasma Protein Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Plasma Protein Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE PLASMA PROTEIN THERAPEUTICS MARKET FORECAST (2016-2021)

14.1 Germany Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.2 France Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.3 UK Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.4 Russia Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.5 Italy Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.6 Spain Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.7 Benelux Plasma Protein Therapeutics Sales Forecast (2016-2021)
14.8 Europe Plasma Protein Therapeutics Sales Forecast by Type (2016-2021)
14.9 Europe Plasma Protein Therapeutics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Plasma Protein Therapeutics
Table Classification of Plasma Protein Therapeutics
Figure Europe Sales Market Share of Plasma Protein Therapeutics by Type in 2015
Figure C1 esterase Inhibitors Picture
Figure Albumins Picture
Figure Immunoglobulins Picture
Figure Coagulation Factors Picture
Figure Others Picture
Table Application of Plasma Protein Therapeutics
Figure Europe Sales Market Share of Plasma Protein Therapeutics by Application in 2015
Figure Hereditary Angioedema Examples
Figure Hemophilia Examples
Figure Primary Immunodeficiency Disorder Examples
Figure Secondary Immunodeficiency Examples
Figure Idiopathic Thrombocytopenic Examples
Figure Others (Kawasaki disease, GBS, CIDP etc) Examples
Figure Germany Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure France Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure UK Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure Russia Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure Italy Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure Spain Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure Benelux Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Plasma Protein Therapeutics Sales and Growth Rate (2011-2021)
Figure Europe Plasma Protein Therapeutics Revenue and Growth Rate (2011-2021)
Table Europe Plasma Protein Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Europe Plasma Protein Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Plasma Protein Therapeutics Sales Share by Manufacturers
Figure 2016 Plasma Protein Therapeutics Sales Share by Manufacturers
Table Europe Plasma Protein Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Europe Plasma Protein Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Plasma Protein Therapeutics Revenue Share by Manufacturers
Table 2016 Europe Plasma Protein Therapeutics Revenue Share by Manufacturers
Table Europe Plasma Protein Therapeutics Sales and Market Share by Type (2011-2016)
Table Europe Plasma Protein Therapeutics Sales Share by Type (2011-2016)
Figure Sales Market Share of Plasma Protein Therapeutics by Type (2011-2016)
Figure Europe Plasma Protein Therapeutics Sales Growth Rate by Type (2011-2016)
Table Europe Plasma Protein Therapeutics Revenue and Market Share by Type (2011-2016)
Table Europe Plasma Protein Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Plasma Protein Therapeutics by Type (2011-2016)
Figure Europe Plasma Protein Therapeutics Revenue Growth Rate by Type (2011-2016)
Table Europe Plasma Protein Therapeutics Sales and Market Share by Countries (2011-2016)
Table Europe Plasma Protein Therapeutics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Plasma Protein Therapeutics by Countries (2011-2016)
Table Europe Plasma Protein Therapeutics Revenue and Market Share by Countries (2011-2016)
Table Europe Plasma Protein Therapeutics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Plasma Protein Therapeutics by Countries (2011-2016)
Table Europe Plasma Protein Therapeutics Sales and Market Share by Application (2011-2016)
Table Europe Plasma Protein Therapeutics Sales Share by Application (2011-2016)
Figure Sales Market Share of Plasma Protein Therapeutics by Application (2011-2016)
Figure Germany Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure Germany Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure Germany Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table Germany Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table Germany Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Germany Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table Germany Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table Germany Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table Germany Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure France Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure France Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure France Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table France Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table France Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table France Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table France Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table France Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table France Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure UK Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure UK Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure UK Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table UK Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table UK Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table UK Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table UK Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table UK Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table UK Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure Russia Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure Russia Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure Russia Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table Russia Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table Russia Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Russia Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table Russia Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table Russia Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table Russia Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure Italy Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure Italy Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure Italy Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table Italy Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table Italy Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Italy Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table Italy Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table Italy Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table Italy Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure Spain Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure Spain Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure Spain Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table Spain Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table Spain Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Spain Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table Spain Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table Spain Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table Spain Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Figure Benelux Plasma Protein Therapeutics Sales and Growth Rate (2011-2016)
Figure Benelux Plasma Protein Therapeutics Revenue and Growth Rate (2011-2016)
Figure Benelux Plasma Protein Therapeutics Sales Price Trend (2011-2016)
Table Benelux Plasma Protein Therapeutics Sales by Manufacturers (2015 and 2016)
Table Benelux Plasma Protein Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Benelux Plasma Protein Therapeutics Sales by Type (2015 and 2016)
Table Benelux Plasma Protein Therapeutics Market Share by Type (2015 and 2016)
Table Benelux Plasma Protein Therapeutics Sales by Application (2015 and 2016)
Table Benelux Plasma Protein Therapeutics Market Share by Application (2015 and 2016)
Table Plasma Protein Therapeutics Basic Information List
Table Baxter International Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter International Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Biotest Basic Information List
Table Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotest Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table CSL Behring Basic Information List
Table CSL Behring Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Behring Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Grifols, S.A. Basic Information List
Table Grifols, S.A. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols, S.A. Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Kedrion Basic Information List
Table Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Octapharma USA Basic Information List
Table Octapharma USA Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma USA Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Shire Plc Basic Information List
Table Shire Plc Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Plc Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table China Biologics Basic Information List
Table China Biologics Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologics Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Kamada Basic Information List
Table Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kamada Plasma Protein Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2015
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders List
Figure Germany Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure France Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure France Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure UK Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Plasma Protein Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Plasma Protein Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Plasma Protein Therapeutics Sales Forecast by Type (2016-2021)
Table Europe Plasma Protein Therapeutics Sales Forecast by Application (2016-2021)